GIMBHI’s daily mental health update — 8/26/26

🔒 Ours Privacy raises $15M Series A for HIPAA-compliant healthcare marketing platform (Anastassia Gliadkovskaya, Fierce Healthcare) — 08/18/26
TL;DR: Ours Privacy raised $15M led by Lightbank and Health Velocity Capital to expand its HIPAA-compliant marketing infrastructure for 200+ healthcare orgs amid rising pixel-tracking enforcement risk.

🇩🇰 Copenhagen’s Aisel Health raises €1.7M pre-seed for AI operating system for psychiatric care (Rahul Raj, EU-Startups) — 08/19/26 TL;DR: Aisel Health closed a €1.7M pre-seed led by Caesar Ventures to expand its psychiatry-specific software that surfaces relevant clinical history for clinicians, with plans to enter the UK market.

🧬 Leal Therapeutics raises $30M Series A extension for schizophrenia and ALS trials (Salong Debbarma, Clinical Trials Arena) — 08/18/26 TL;DR: Leal Therapeutics closed a $30M Series A extension with new investor Eli Lilly joining to fund Phase Ib/IIa data readout for schizophrenia drug LTX-001 and advance ALS therapy LTX-002.

🇮🇳 Lissun raises ₹48 Cr Series A led by Colossa Ventures for children with developmental delays (Gyan Vardhan, Entrackr) — 08/18/26 TL;DR: Gurugram-based Lissun raised ₹48 Cr (~$5.5M) led by Colossa Ventures to expand its Sunshine by LISSUN child development centres to 50 locations and build AI-led tools for autism, ADHD, and speech disorders.